Plus Therapeutics News

Plus Therapeutics Is Maintained at Buy by Ascendiant Capital

Dow JonesSep 3 17:45

Buy Rating Affirmed for Plus Therapeutics Amid Strong Clinical Results and Positive Financial Outlook

TipRanksAug 20 16:57

Maxim Group Maintains Plus Therapeutics(PSTV.US) With Buy Rating, Maintains Target Price $4

Futu NewsAug 17 01:32

Buy Rating Affirmed for Plus Therapeutics on Strong Financials and Promising Clinical Trials

TipRanksAug 17 00:47

Plus Therapeutics Analyst Ratings

BenzingaAug 16 20:20

HC Wainwright & Co. Reiterates Buy on Plus Therapeutics, Maintains $8 Price Target

BenzingaAug 16 20:20

Buy Rating Affirmed for Plus Therapeutics Amidst Promising Clinical Trial Results

TipRanksAug 16 02:37

Buy Rating Affirmed for Plus Therapeutics on Strong Clinical Progress and Robust Financial Health

TipRanksJun 3 18:06

Plus Therapeutics Inc: Ascendiant Capital Markets cuts target price from $22 to $21

Zhitong FinanceJun 3 12:38

Buy Rating Justified by Plus Therapeutics' Strategic Acquisition and Strong Pipeline Prospects

TipRanksMay 23 19:41

Analysts' Top Healthcare Picks: OrganiGram Holdings (OGI), Plus Therapeutics (PSTV)

TipRanksMay 18 04:15

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), Plus Therapeutics (PSTV) and Argenx Se (ARGX)

TipRanksMay 10 20:45

Buy Rating Affirmed for Plus Therapeutics Amidst Clinical Advancements and Industry Tailwinds

TipRanksMar 23 00:50

Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Milestone Pharmaceuticals (MIST)

TipRanksMar 23 00:40

Buy Rating Affirmed for Plus Therapeutics Amid Strong Financials and Promising Clinical Trials

TipRanksMar 7 23:45

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), HUTCHMED (HCM) and Plus Therapeutics (PSTV)

TipRanksNov 29, 2023 05:40

Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV), Ambrx Biopharma (AMAM) and Marinus (MRNS)

TipRanksNov 21, 2023 19:20

Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV), Beyond Air (XAIR) and Ovid Therapeutics (OVID)

TipRanksNov 4, 2023 02:50

Analysts Conflicted on These Healthcare Names: Geron (GERN), Silk Road Medical (SILK) and Plus Therapeutics (PSTV)

TipRanksNov 3, 2023 00:50

Promising Clinical Developments Drive Buy Rating for Plus Therapeutics: Analysis of Recent Trials and Future Prospects

TipRanksOct 12, 2023 01:45